KeimOUT

KeimOUT: Rapid diagnosis of multi-resistant bacteria

Every year, over 600,000 hospital patients in Germany become infected with so-called nosocomial pathogens, which are increasingly resistant to conventional medicines. This causes great suffering and burdens the economy with around €1.3 billion annually. Studies suggest that more than 60% of infections are potentially preventable, but these fail due to inefficient diagnosis of the germs in time.

The novel combination of photonic and micro/nanotechnological approaches investigated in this project can in principle reduce the time for reliable detection and measurement of resistance profiles to a few hours. The procedure can be used without complex laboratory infrastructure and specially trained personnel, enabling routine use at hospital wards or in medical practices.

Lionex GmbH develops growth parameters for short-term measurement of resistant hospital germs and takes over product development, certification, and marketing after the project ends.

Partners

Max-Planck-Institut für biophysikalische Chemie (Göttingen), MicroDiscovery GmbH (Berlin), OFFIS e.V. (Oldenburg), Technische Universität Braunschweig, PCO AG (Kelheim).

Coordinator: Prof. Dr. Mahavir Singh, Lionex GmbH